ROMANO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 3.581
EU - Europa 3.223
AS - Asia 2.190
SA - Sud America 176
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 9.223
Nazione #
US - Stati Uniti d'America 3.516
SG - Singapore 859
IT - Italia 678
CN - Cina 601
IE - Irlanda 471
UA - Ucraina 453
SE - Svezia 378
GB - Regno Unito 362
TR - Turchia 353
FR - Francia 300
DE - Germania 229
IN - India 225
BR - Brasile 138
FI - Finlandia 125
RU - Federazione Russa 85
CA - Canada 44
HK - Hong Kong 43
AT - Austria 38
VN - Vietnam 30
NL - Olanda 21
PL - Polonia 18
PE - Perù 17
ES - Italia 15
BE - Belgio 14
CZ - Repubblica Ceca 13
EG - Egitto 12
IR - Iran 12
EU - Europa 11
BD - Bangladesh 10
AU - Australia 9
BZ - Belize 9
JP - Giappone 9
ZA - Sudafrica 9
AR - Argentina 8
IL - Israele 8
KR - Corea 7
MX - Messico 6
CL - Cile 5
PK - Pakistan 5
TW - Taiwan 5
MA - Marocco 4
RO - Romania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
IQ - Iraq 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EE - Estonia 2
KE - Kenya 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.223
Città #
Chandler 666
Singapore 616
Jacksonville 517
Dublin 465
Southend 268
Princeton 207
Izmir 201
Nanjing 132
Ashburn 124
New York 120
Santa Clara 114
Dearborn 112
The Dalles 110
Boardman 107
Chieti 101
Beijing 91
Altamura 90
Wilmington 88
Cambridge 80
Ann Arbor 73
Tongling 66
Nanchang 63
Pescara 53
Rome 44
Los Angeles 41
Helsinki 35
Montesilvano 34
Vienna 33
Hong Kong 30
Munich 30
San Mateo 29
Hebei 24
Washington 24
Woodbridge 24
Tianjin 23
Dong Ket 22
Shenyang 22
Düsseldorf 21
Jiaxing 21
Kunming 21
Falls Church 20
Houston 19
Nuremberg 19
Augusta 18
Toronto 18
Montreal 17
Brussels 14
Cornaredo 14
Frankfurt am Main 14
Grevenbroich 14
Milan 13
San Francisco 13
Central 12
Changsha 12
Cairo 10
Ica 10
Orange 10
San Buono 10
Seattle 10
Turku 10
Brno 9
Brooklyn 9
Tokyo 9
Ascoli Piceno 8
Hangzhou 8
Jinan 8
London 8
Boston 7
Chicago 7
Lanzhou 7
Leawood 7
Lima 7
Meylan 7
Norwalk 7
Piotrkow Trybunalski 7
São Paulo 7
Warsaw 7
Ancona 6
Changchun 6
Chengdu 6
Johannesburg 6
Ningbo 6
Tappahannock 6
Fuzhou 5
Hefei 5
Lanciano 5
Madrid 5
Melbourne 5
Redwood City 5
Saint-prix 5
Shanghai 5
Vasto 5
Amsterdam 4
Ardabil 4
Auburn Hills 4
Bari 4
Columbus 4
Falkenstein 4
Guangzhou 4
Haikou 4
Totale 5.461
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 279
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 164
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 152
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 148
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 145
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 141
Establishment and long-term culture of human cystic fibrosis endothelial cells 141
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 140
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 139
Mechanisms of endothelial cell dysfunction in cystic fibrosis 137
Pentraxin 3 and platelet activation in obese patients after gastric banding 136
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 132
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 120
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 110
Lipoxins, resolvins, and the resolution of inflammation 108
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 107
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 107
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 107
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 106
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 105
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 105
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 104
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 103
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 102
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 102
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 101
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 100
Increased soluble CD40L levels in cystic fibrosis 99
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 99
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 98
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 98
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 98
Lipoxin receptors 97
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 97
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 96
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 95
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 94
Epigenetic regulation of the formyl peptide receptor 2 gene 94
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 93
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 92
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 91
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 90
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 89
Transcellular regulation of eicosanoids biosyntesis 89
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 89
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 89
Leptin increase is associated with markers of the hemostatic system in obese healthy women 88
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 88
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 88
Homocysteine modulates the CD40/CD40L system 87
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 86
Increased levels of soluble P-selectin in hypercholesterolemic patients 86
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 83
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 83
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 82
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 82
Induction of functional Lipoxin A4 receptors in HL-60 cells 81
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 80
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 79
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 79
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 79
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 78
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 78
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 78
Reduced platelet mitogenic activity in myeloproliferative disorders 78
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 78
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 78
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 78
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 77
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 77
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 76
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 76
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 76
Lipoxin and aspirin-triggered lipoxins 76
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 75
Lipoxin synthase activity of human platelet 12-Lipoxygenase 74
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 74
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 72
Inflammation resolution: does the bone marrow have a say? 72
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 71
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 70
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 70
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 69
Human alveolar macrophages generate 15-HETE and can produce lipoxins 69
Ligand bias and its association with pro-resolving actions of melanocortin drugs 69
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 69
Lipoxin generation by permeabilized human platelets 68
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 67
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 67
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 66
Endothelial perturbation in cystic fibrosis. 66
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 65
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 63
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 63
Lipoxin analogs and lipoxin formation in vivo 63
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 60
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 59
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 59
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 57
The Resolution Approach to Cystic Fibrosis Inflammation 57
Totale 9.217
Categoria #
all - tutte 41.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021807 102 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/2026132 132 0 0 0 0 0 0 0 0 0 0 0
Totale 9.630